Life Sciences Report May 2017

In this issue of Life Sciences Report you can read about the review of the system for funding, reimbursing and pricing of medicines as well as the new clinical trials regulation and the two new regulations for medical devices.

We also provide you with an overview of the European Commission’s nuanced approach in determining the market for pharmaceuticals in competition cases. Our guest contributor, Jan Heidebrandt, Manager, Compliance and Regulatory at Swedish Medtech, writes about the new regulations for medical devices.

Enjoy your reading, and feel welcome to contact Setterwalls’ Life Sciences group for more information.